Kant Ks

Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.

Pia Glas-Greenwalt, Kant Ks, C. Allen et al. · PubMed · 1984 · 59 citations

Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod.

Kant Ks, Pollak Ve, Akinsan K Dosekun et al. · PubMed · 1985 · 38 citations

Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura.

Pia Glas-Greenwalt, Hall Jm, Panke Tw et al. · PubMed · 1986 · 37 citations

Diffuse proliferative lupus nephritis: long-term observations in patients treated with ancrod.

Sundaram Hariharan, Pollak Ve, Kant Ks et al. · PubMed · 1990 · 17 citations

Glomerular Disease, Renal Pathology, Immunology +21

Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).

Du Xh, Pia Glas-Greenwalt, Kant Ks et al. · PubMed · 1985 · 15 citations

Glomerular Disease, Hypertension, Renal Pathology +23